Total submissions: 28
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075440 | SCV000106437 | likely benign | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF 1% in African population |
Invitae | RCV001083015 | SCV000166246 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000034543 | SCV000170300 | benign | not provided | 2018-12-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 15133479, 18809606, 26332594, 22703879, 24055113, 16995940, 21056691, 21681552, 25637381, 22736432, 22949387, 20981092, 24728327, 12115348, 27153395, 18561205, 18383312, 16341804, 24933000, 17510385, 31784484) |
Ambry Genetics | RCV000130675 | SCV000185561 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000121364 | SCV000226564 | benign | not specified | 2015-05-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000121364 | SCV000595805 | likely benign | not specified | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000130675 | SCV000684785 | benign | Hereditary cancer-predisposing syndrome | 2015-10-15 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659875 | SCV000781762 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000121364 | SCV000805960 | benign | not specified | 2017-12-01 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000034543 | SCV000889394 | benign | not provided | 2022-06-09 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000659875 | SCV001136430 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000659875 | SCV001305814 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2019-04-23 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
ARUP Laboratories, |
RCV000034543 | SCV001433781 | likely benign | not provided | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000130675 | SCV002528699 | benign | Hereditary cancer-predisposing syndrome | 2021-04-27 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000121364 | SCV002550461 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496517 | SCV002812017 | likely benign | Mismatch repair cancer syndrome 1; Muir-Torré syndrome; Colorectal cancer, hereditary nonpolyposis, type 2 | 2021-10-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034543 | SCV002821176 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | MLH1: BP4 |
KCCC/NGS Laboratory, |
RCV000659875 | SCV004015872 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000130675 | SCV004228023 | benign | Hereditary cancer-predisposing syndrome | 2023-11-14 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000075440 | SCV004843244 | benign | Lynch syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000659875 | SCV000043328 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-10-03 | no assertion criteria provided | research | BA1 based on allele frequency in AFR of 0.008856 in gnomAD. |
ITMI | RCV000121364 | SCV000085545 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
CSER _CC_NCGL, |
RCV000148615 | SCV000190330 | likely benign | Endometrial carcinoma | 2014-06-01 | no assertion criteria provided | research | |
Mayo Clinic Laboratories, |
RCV000121364 | SCV000257076 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV000034543 | SCV000592430 | uncertain significance | not provided | flagged submission | clinical testing | ||
True Health Diagnostics | RCV000130675 | SCV000788021 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-10 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000121364 | SCV002034149 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000121364 | SCV002034431 | benign | not specified | no assertion criteria provided | clinical testing |